Pharmosa Biopharm 

TWD26.65
0
-TWD0.45-1.66% 05:30 Today

Statistics

Day High
27.1
Day Low
26.65
52W High
58.7
52W Low
26.45
Volume
105,635
Avg. Volume
146,991
Mkt Cap
3.44B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-570.63%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
67.27MRevenue
-383.85MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Show More
CEO
Pei Kan
Employees
15
Country
Taiwan
ISIN
TW0006875008

Listings

0 Comments

Share your thoughts

FAQs

What is Pharmosa Biopharm stock price today?▼
The current price of 6875.TWO is TWD26.65 TWD — it has decreased by -1.66% in the past 24 hours. Watch Pharmosa Biopharm stock price performance more closely on the chart.
What is Pharmosa Biopharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Pharmosa Biopharm stocks are traded under the ticker 6875.TWO.
Is Pharmosa Biopharm stock price growing?▼
6875.TWO stock has fallen by -0.56% compared to the previous week, the month change is a -10.87% fall, over the last year Pharmosa Biopharm has showed a -48.15% decrease.
What is Pharmosa Biopharm market cap?▼
Today Pharmosa Biopharm has the market capitalization of 3.44B
What is Pharmosa Biopharm revenue for the last year?▼
Pharmosa Biopharm revenue for the last year amounts to 67.27M TWD.
What is Pharmosa Biopharm net income for the last year?▼
6875.TWO net income for the last year is -383.85M TWD.
How many employees does Pharmosa Biopharm have?▼
As of November 3, 2026, the company has 15 employees.
In which sector is Pharmosa Biopharm located?▼
Pharmosa Biopharm operates in the Health & Wellness sector.
When did Pharmosa Biopharm complete a stock split?▼
Pharmosa Biopharm has not had any recent stock splits.
Where is Pharmosa Biopharm headquartered?▼
Pharmosa Biopharm is headquartered in Taipei City, Taiwan.